NCT00753545 2025-02-03Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian CancerAstraZenecaPhase 2 Completed265 enrolled 25 charts 1 FDA
NCT00516373 2024-02-22A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)AstraZenecaPhase 1 Completed98 enrolled
NCT01444456 2017-03-20Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaAmgenCompleted1,262 enrolled 14 charts
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled
NCT00270166 2011-05-18The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3 Completed201 enrolled
NCT00121030 2007-12-24Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to ChemotherapyAmgenPhase 2 Completed